73× trailing P/E sits on a moat that just lost the largest forward tender in industry history.

• Premium pricing. Stock trades at 73× TTM P/E and ~10× book — well above the listed-OEM peer median (Eicher 38×, Ashok Leyland 28×) on the second-lowest ROCE in the peer set. The premium is paying for FY26 consensus of +47% revenue and +50% PAT.
• The moat lost its first allocation test. December 2025 PM E-DRIVE 10,900-bus award — the largest e-bus tender in Indian history — handed Olectra 1,785 buses (16%). PMI Electro took 5,210 (48%) and EKA Mobility 3,485 (32%). Forward share publicly contradicts the 29% installed-base narrative.
• Guidance has missed for three years. FY23 1,000 → 563 (56%); FY24 2,500–3,000 → 558 (22%); FY25 5,000 → 972 (19%); FY26 cut to 1,500–2,000 from 10,000 initial. The 73× multiple rests on a number management has missed by 60–95% three years running.

The listed entity earns the OEM margin; the 12-year per-km annuity flows to the parent.

• System multiple, slice-of-system equity. Olectra builds the bus and invoices it to associate SPVs in the Evey Trans cluster, where it holds 1–26%. The 12-year per-kilometre revenue stream and the operating IRR sit at the SPV / MEIL parent layer — Olectra books a one-time OEM margin. The right anchor is an OEM multiple (peer median 30–40×), not a system multiple.
• The MSR tell. During FY25 — the year of the Maharashtra MSRTC cancellation row — Olectra's stake in the EVEY-MSR SPV was cut from 34% to 1%. The founder-CMD K.V. Pradeep Reddy resigned in June 2025, the month after the row; the 25th AGM (Dec-2025) approved an aggregate ~$1.8B related-party ceiling — ~8.6× FY25 revenue — across EVEY entities and MEIL (per FY26 AGM resolutions, dossier-aggregated). Contingent liabilities up 87× to $63M in 24 months.
• Margin reset is now, not FY28. EV-segment EBITDA already compressed to 11.8% in H1 FY26 (from 14.9% H1 FY25). Q3 FY26 printed revenue +29% but PBT just +3% as Phase-I depreciation and interest absorbed leverage below the line. Management's own long-term guide is 10–12%.

Revenue compounding at ~41% over seven years; cash conversion is the catch.

Operating margin swung from −9% in FY19 to 15% in FY25 as the e-bus mix scaled and the loss-making commissioning phase faded. The catch: every dollar of incremental sales has historically needed roughly one dollar of incremental working capital, and the FY26 capex super-cycle (CWIP ~$23M at Sep-25) is funded by debt. Seetharampur Phase-I capitalised in January now drips depreciation through the P&L without commensurate volume — FY27 free cash turning positive is the bull's must-deliver.

Three front-loaded events decide whether the multiple defends or compresses.

• Q4 FY26 results, late May. First mark on the 1,500–2,000 delivery guide — 881 delivered through 9M, so Q4 must do 619–1,119. Watch Q4 EBITDA defence versus the 14% anchor, the Phase-I depreciation step-up, and new MD Mahesh Babu's first FY27 framework.
• PM E-DRIVE 1,785-bus LoI conversion. Management said on 3-Feb that conversion was "in the coming month" — overdue. The mechanic that decides whether the December allocation translates into FY27 revenue at L1 pricing or echoes the BEST overload-tariff dispute and gets repriced on the counterparty's terms.
• Next CESL multi-state tender (Q1–Q2 FY27). ~3,000+ buses for the Mumbai / Pune / Hyderabad cluster. Olectra ≥30% allocation at unchanged L1 pricing invalidates the moat-failure thesis; ≤20% repeat with PMI / EKA taking 70%+ combined would confirm structural share loss and likely trigger FY27 sell-side cuts.